Cargando…

Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn Disease

IMPORTANCE: Biological therapies have revolutionized inflammatory bowel disease management, but many patients do not respond to biological monotherapy. Identification of likely responders could reduce costs and delays in remission. OBJECTIVE: To identify patients with Crohn disease likely to be dura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waljee, Akbar K., Wallace, Beth I., Cohen-Mekelburg, Shirley, Liu, Yumu, Liu, Boang, Sauder, Kay, Stidham, Ryan W., Zhu, Ji, Higgins, Peter D. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512283/ https://www.ncbi.nlm.nih.gov/pubmed/31074823 http://dx.doi.org/10.1001/jamanetworkopen.2019.3721

Ejemplares similares

The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease
por: Stidham, Ryan W, et al.
Publicado: (2021)

Association of Continuity of Care With Outcomes in US Veterans With Inflammatory Bowel Disease
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2020)

Association of Anti–Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2021)

Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis
por: Stidham, Ryan W., et al.
Publicado: (2019)

62541 Continuity of Care for Patients with Chronic Gastrointestinal Disease: A Latent Class Analysis of Patients With High-Intensity Specialty Care Needs
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2021)

Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
por: Berinstein, Elliot M., et al.
Publicado: (2023)

Fr105 CONTINUITY OF CARE FOR PATIENTS WITH CHRONIC GASTROINTESTINAL DISEASE: A LATENT CLASS ANALYSIS OF PATIENTS WITH HIGH-INTENSITY SPECIALTY CARE NEEDS
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2021)

Body Fat Composition Assessment Using Analytic Morphomics Predicts Infectious Complications After Bowel Resection in Crohn's Disease
por: Stidham, Ryan W., et al.
Publicado: (2015)

Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease
por: Gan, Ryan W., et al.
Publicado: (2021)

CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital
por: Govani, Shail M., et al.
Publicado: (2018)

Social Network Diversity and the Daily Burden of Inflammatory Bowel Disease
por: Greene-Higgs, LaVana, et al.
Publicado: (2023)

Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease
por: Stidham, Ryan W., et al.
Publicado: (2017)

Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic
por: Jacob, Janson, et al.
Publicado: (2022)

Reinforcement learning evaluation of treatment policies for patients with hepatitis C virus
por: Oselio, Brandon, et al.
Publicado: (2022)

Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn’s disease
por: Newman, Kira L., et al.
Publicado: (2023)

Cold snare polypectomy for non-pedunculated colon polyps greater than 1 cm
por: Piraka, Cyrus, et al.
Publicado: (2017)

Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease care
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2022)

Machine learning models to predict disease progression among veterans with hepatitis C virus
por: Konerman, Monica A., et al.
Publicado: (2019)

Crohn’s disease in remission or simply smouldering?
por: Gaya, Daniel R.
Publicado: (2015)

Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
por: Sheehan, Jessica L., et al.
Publicado: (2023)

Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C
por: Konerman, Monica A., et al.
Publicado: (2017)

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

42956 Patterns and impact of long-term glucocorticoid use on RA patients at risk for major adverse cardiac events
por: Wallace, Beth I., et al.
Publicado: (2021)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
por: Waljee, Akbar K., et al.
Publicado: (2018)

Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
por: Waljee, Akbar K., et al.
Publicado: (2016)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Lactobacillus GG in inducing and maintaining remission of Crohn's disease
por: Schultz, Michael, et al.
Publicado: (2004)

Targeted Gene Sequencing in Children with Crohn’s Disease and Their Parents: Implications for Missing Heritability
por: Chen, Jiun-Sheng, et al.
Publicado: (2018)

Methylation quantitative trait loci are largely consistent across disease states in Crohn’s disease
por: Venkateswaran, Suresh, et al.
Publicado: (2022)

Testing Practices, Interpretation, and Diagnostic Evaluation of Iron Deficiency Anemia by US Primary Care Physicians
por: Read, Andrew J., et al.
Publicado: (2021)

Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative Stress
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019)

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
por: Chaparro, María, et al.
Publicado: (2022)

Adapted time-varying covariates Cox model for predicting future cirrhosis development performs well in a large hepatitis C cohort
por: Beste, Lauren A., et al.
Publicado: (2021)

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
por: Wu, Kai-Chun, et al.
Publicado: (2016)

Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years
por: Morin, Charles M., et al.
Publicado: (2020)

Salvaged single-unit cord blood transplantation for 26 patients with hematologic malignancies not in remission
por: Yao, W., et al.
Publicado: (2015)

Overuse of glucocorticoids in rheumatoid arthritis: a national survey of primary care physicians
por: Wallace, Beth I, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hj9ldk6k1pg4ldhq95q90gvm2